It’s official, Warner Bros. Discovery has acquired worldwide rights to the buzzy Sundance documentary film “Super/Man: The Christopher Reeve Story” in a deal said to be worth $15 million.
Announcing the deal in a press release, DC Studios, Warner Bros. Motion Pictures, HBO, CNN Films and Max all jointly sought out the project which is a natural home for the feature as Warners owns the Superman character across film, comics and other media.
The various branches of the WBD empire will collaborate on the film’s global release across its theatrical and home viewing release windows. The film features extensive archival footage and interviews with Reeve’s inner circle and family as it looks at his life, film and advocacy work.
A WBD spokesperson said in a statement:
“Everyone at Warner Bros. Discovery is incredibly proud to come together as one company to partner with Christopher Reeve’s family and the filmmakers behind ‘Super/Man: The Christopher Reeve Story’ and bring his personal journey to audiences the world over. WBD’s DC Studios, Warner Bros. Motion Pictures, HBO, CNN Films and Max are grateful for the opportunity to honor one of our company’s most cherished creative partners and to celebrate Christopher’s rich life and career.”
The deal comes ahead of James Gunn’s “Superman: Legacy,” starring David Corentswet in the role,” going into production next month. This week saw composer John Murphy hired onto that project.
“Super/Man” is not the only acquistion of late as Paramount Pictures has acquired the action film “Novocaine” starring “The Boys” alum Jack Quaid and “Prey” breakout Amber Midthunder.
Robert Olsen and Dan Berk are directing from a Lars Jacobson script and filming begins in April in South Africa.
Quaid will play a sheltered bank executive with a rare genetic condition that prevents him from feeling physical pain.
When his bank is robbed and one of his co-workers kidnapped, his greatest liability becomes his greatest strength.
The post “Super/Man,” “Novocaine” Officially Acquired appeared first on Dark Horizons.